Infectious Disease and Immunology, Therapy Discovery and Development
Professor Grill, who joined KGI in August 2013, is the Dean of Research at KGI. In addition to teaching courses at KGI, he also teaches undergraduates at the Keck Science Department of The Claremont Colleges.
His lab’s research at KGI is focused on low-cost vaccines for developing countries. The primary collaborator for this effort is the Botswana Vaccine Institute in Gaborone, Botswana. The focus of these efforts has been to address animal diseases that are devastating to smallholder farmers in Africa. With the disastrous COVID-19 outbreak, the research is now targeting the development of low-cost COVID-19 vaccines for the African countries.
Dr. Grill was one of two founders who started Large Scale Biology Corporation (LSBC) in 1987, which became a publicly-held company in 2000. The biotechnology company made therapeutic drugs, pharmaceuticals, and vaccines using a unique plant viral gene expression technology. In the development of these drugs, Dr. Grill developed innovative bioprocessing technology to produce and purify the molecules expressed in plants. They had successful animal and human clinical trials and were able to produce patient-specific vaccines as a therapeutic treatment for non-Hodgkin’s lymphoma cancer patients.
Dr. Grill received his PhD from the University of California, Riverside in 1979. He has published over 25 scientific papers and is an inventor on more than 30 issued US and world patents.